Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 27.42
+0.31 (1.14%)
Jun 18, 2026, 3:00 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 11.95 billion as of June 18, 2026. Its market cap has increased by 27.44% in one year.
Market Cap
11.95B
Enterprise Value
13.91B
Revenue
745.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.42
Market Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 11.95B, an increase of 22.08%. That is a compound annual growth rate of 4.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 11.95B | -22.21% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
| Jan 18, 2022 | 9.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 14.48B |
| Jinyu Bio-technology | 12.86B |
| Anhui Anke Biotechnology (Group) | 12.79B |
| Tibet Cheezheng Tibetan Medicine | 11.12B |
| HitGen | 11.03B |
| Inner Mongolia Furui Medical Science | 10.63B |
| Chengzhi | 10.51B |
| Jiangxi Fushine Pharmaceutical | 10.49B |